Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

198 papers

Showing 109-120 of total 198 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Sekita A; Sprügel MI; Balk S; Haupenthal D; Engelhorn T; Schmidt MA; Doerfler A; Oberstein TJ; Maler JM; Kornhuber J; Lewczuk P; Rothhammer V; Schwab S; Kuramatsu JB; Sembill JA

2026PubMedDirectly related

Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell-specific extracellular vesicles.

Kumar A; Sharma M; Su Y; Singh S; Tanley JE; Casanova R; Hsu FC; Craft S; Mielke MM; Hughes TM; Deep G

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedDirectly related

Circulating neuron-derived cfDNA for blood-based detection of Alzheimer's and other neurodegenerative conditions.

Pollard C; Miller R; Stirland I; Keni M; Jenkins A; Saito E; Hill JT; Jenkins T

Jan 1, 2026Frontiers in neurology

2026PubMedDirectly related

Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.

Mishra R; Chauhan N; Agrawal KK

Jan 1, 2026Current neurovascular research

2025CrossrefDirectly related0 citations

Longitudinal analysis of human plasma biomarkers for Alzheimer's disease: Phosphorylated Tau‐217, Phosphorylated Tau‐181, and Glial fibrillation acidic protein

MayaRae N Mugosa; Jefferson W Kinney; Lorenzo Gabriel Pasia; Mason Jonah; Isabella Hou; Aaron Ritter

Dec 1, 2025Alzheimer's & Dementia

2025CrossrefDirectly related0 citations

Effects on Blood Neurodegeneration Biomarkers of a Randomized Hearing Rehabilitation Intervention

Nicholas Reed; James Pike; Jennifer Deal; Priya Palta; Josef Coresh

Dec 1, 2025Innovation in Aging

2025CrossrefDirectly related0 citations

Blood-Based Biomarkers of Aging and Neurodegeneration in Longitudinal Cohort Studies of Brain Aging

Natascha Merten; Josef Coresh; Bryan James

Dec 1, 2025Innovation in Aging

2025CrossrefSupporting evidence41 citations

Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration

Elise A. Kellett; Adekunle T. Bademosi; Adam K. Walker

May 8, 2025Molecular Neurodegeneration

2025CrossrefDirectly related40 citations

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

Dietmar Rudolf Thal; Koen Poesen; Rik Vandenberghe; Steffi De Meyer

Mar 14, 2025Molecular Neurodegeneration

2024OpenAlexSupporting evidence0 citations

Vascular Aging Markers and Blood Biomarkers of Neurodegeneration

Vanessa A. Guzman; Maliyah Panton; Salwa Rahman; Antonio J. Spagnolo Allende; Mitchell S.V. Elkind; Tatjana Rundek; Randolph S. Marshall; Stephanie Cosentino; Jennifer J. Manly; José Gutierrez

Dec 1, 2024Alzheimer s & Dementia

2024CrossrefDirectly related0 citations

Risk Factors Associated with Alzheimer Disease and Role of Diagnostic Citeria in Alzheimer Disease

Tara Devi; Sudhir Sharma

Sep 8, 2024Scientific Research Journal of Clinical and Medical Sciences

2024OpenAlexDirectly related889 citations

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

Nicholas J. Ashton; Wagner S. Brum; Guglielmo Di Molfetta; Andréa Lessa Benedet; Burak Arslan; Erin M. Jonaitis; Rebecca E. Langhough; Karly Alex Cody; Rachael E. Wilson; Cynthia M. Carlsson; Eugeen Vanmechelen; Laia Montoliu‐Gaya; Juan Lantero‐Rodriguez; Nesrine Rahmouni; Cécile Tissot; Jenna Stevenson; Stijn Servaes; Joseph Therriault; Tharick A. Pascoal; Alberto Lleó; Daniel Alcolea; Juan Fortea; Pedro Rosa‐Neto; Sterling C. Johnson; Andreas Jeromin; Kaj Blennow; Henrik Zetterberg

Jan 22, 2024JAMA Neurology